Alector (ALEC) Current Deferred Revenue (2018 - 2026)
Alector's (ALEC) quarterly Current Deferred Revenue came in at $6.7 million in Q1 2026, down 69.23% year-on-year from $21.8 million in Q1 2025, and up 0.58% on a QoQ basis from $6.7 million in Q4 2025.
Alector (ALEC) Current Deferred Revenue (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Current Deferred Revenue data on file, last reported at $6.7 million in Q1 2026.
- On a quarterly basis, Current Deferred Revenue fell 69.23% year-over-year to $6.7 million in Q1 2026; TTM through Mar 2026 was $6.7 million, a 69.23% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, down 71.75% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $6.7 million, up from $6.7 million in the prior quarter.
- Over the last five years, Current Deferred Revenue for ALEC reached as high as $444.9 million in Q1 2022 and fell as low as $454800.0 in Q3 2022.
- Historically, Current Deferred Revenue has averaged $90.8 million across 5 years, with a median of $55.4 million in 2024.
- Across the five-year window, Current Deferred Revenue slumped 99.52% in 2022 and soared 17613.5% in 2023, its largest moves.
- Year by year, Current Deferred Revenue stood at $48.2 million in 2022, then soared by 72.04% to $83.0 million in 2023, then plunged by 71.48% to $23.7 million in 2024, then plunged by 71.75% to $6.7 million in 2025, then advanced by 0.58% to $6.7 million in 2026.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $6.7 million in Q1 2026, $6.7 million in Q4 2025, and $11.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.72 Mn |
| Dec 31, 2025 | 6.68 Mn |
| Sep 30, 2025 | 11.74 Mn |
| Jun 30, 2025 | 13.40 Mn |
| Mar 31, 2025 | 21.85 Mn |
| Dec 31, 2024 | 23.66 Mn |
| Sep 30, 2024 | 55.43 Mn |
| Jun 30, 2024 | 63.96 Mn |
| Mar 31, 2024 | 73.35 Mn |
| Dec 31, 2023 | 82.98 Mn |
| Sep 30, 2023 | 80.56 Mn |
| Jun 30, 2023 | 68.55 Mn |
| Mar 31, 2023 | 433.60 Mn |
| Dec 31, 2022 | 48.23 Mn |
| Sep 30, 2022 | 454,800.00 |
| Jun 30, 2022 | 106.99 Mn |
| Mar 31, 2022 | 444.90 Mn |
| Dec 31, 2021 | 90.80 Mn |
| Sep 30, 2021 | 94.68 Mn |
| Jun 30, 2021 | 25.42 Mn |